Lenvatinib in combination with golvatinib overcomes hepatocyte growth factor pathway‐induced resistance to vascular endothelial growth factor receptor inhibitorTakayuki Nakagawa, Yasuhiro Funahashi|Cancer Science|2014Cited by 39
Low-Dose Cyclophosphamide and Piroxicam Inhibit Growth, Migration, and Invasion of Canine Oral Malignant Melanoma Cell LineNan Choisunirachon, Takayuki Nakagawa|The Thai Journal of Veterinary Medicine|2015Cited by 1